Found: 4278
Select item for more details and to access through your institution.
Phase 2 study of pegylated liposomal doxorubicin plus cyclophosphamide, vincristine/vindesine, and prednisone in newly diagnosed PTCL: 8-year results.
- Published in:
- Oncologist, 2024, v. 29, n. 9, p. 819, doi. 10.1093/oncolo/oyae108
- By:
- Publication type:
- Article
Thrombosis of the lower right limb in an 11-year-old boy - the first manifestation of systemic lupus erythematosus triggered by SARS-CoV-2 infection.
- Published in:
- Polish Journal of Pediatrics / Pediatria Polska, 2024, v. 99, n. 2, p. 175, doi. 10.5114/polp.2024.140857
- By:
- Publication type:
- Article
Travmaya Bağlı Fraktür Gelişimi Sonucu Multipl Miyelom Tanısı Alan Hastanın Hemşirelik Bakımı: Olgu Sunumu.
- Published in:
- Journal of Ege University Nursing Faculty (JEUNF), 2024, v. 40, n. 2, p. 293, doi. 10.53490/egehemsire.1153032
- By:
- Publication type:
- Article
Long-Term Outcomes of Adjuvant Trastuzumab for 9 Weeks or 1 Year for ERBB2-Positive Breast Cancer: A Secondary Analysis of the SOLD Randomized Clinical Trial.
- Published in:
- JAMA Network Open, 2024, v. 7, n. 8, p. e2429772, doi. 10.1001/jamanetworkopen.2024.29772
- By:
- Publication type:
- Article
Molecular Factors Predicting Ovarian Chemotoxicity in Fertile Women: A Systematic Review.
- Published in:
- Cancers, 2024, v. 16, n. 16, p. 2793, doi. 10.3390/cancers16162793
- By:
- Publication type:
- Article
Severe Post-Viral Polymyositis after COVID-19 in Childhood: A Case Report and Literature Review.
- Published in:
- Children, 2024, v. 11, n. 8, p. 1011, doi. 10.3390/children11081011
- By:
- Publication type:
- Article
Surface contamination of cytotoxic medicine in preparation and patient care areas in Australian hospitals: a retrospective cross‐sectional study.
- Published in:
- Journal of Pharmacy Practice & Research, 2024, v. 54, n. 4, p. 306, doi. 10.1002/jppr.1925
- By:
- Publication type:
- Article
Analyzing histopathological aspects and cell populations in orbital inflammatory involvement in systemic diseases: A case series from the Rheumatologist's perspective.
- Published in:
- CytoJournal, 2024, v. 21, p. 1, doi. 10.25259/Cytojournal_21_2024
- By:
- Publication type:
- Article
Challenges with sirolimus experimental data to inform QSP model of post‐transplantation cyclophosphamide regimens.
- Published in:
- CTS: Clinical & Translational Science, 2024, v. 17, n. 8, p. 1, doi. 10.1111/cts.70014
- By:
- Publication type:
- Article
Low dose intravenous immunoglobulin in addition to cyclophosphamide in systemic sclerosis: Single centre experience.
- Published in:
- Wiener Klinische Wochenschrift, 2021, v. 133, n. 19/20, p. 1070, doi. 10.1007/s00508-020-01669-y
- By:
- Publication type:
- Article
Cyclophosphamide in alveolar hemorrahge due to leptospirosis.
- Published in:
- 2010
- By:
- Publication type:
- Letter
Cyclophosphamide in pulmonary alveolar hemorrhage due to leptospirosis.
- Published in:
- Indian Journal of Critical Care Medicine, 2009, v. 13, n. 2, p. 79, doi. 10.4103/0972-5229.56053
- By:
- Publication type:
- Article
Effect of monthly cyclophosphamide pulses on skin sclerosis in systemic sclerosis.
- Published in:
- 2021
- By:
- Publication type:
- letter
Stevens-Johnson syndrome-like reaction without mucosal lesions associated with cyclophosphamide.
- Published in:
- 2019
- By:
- Publication type:
- Case Study
Cancrum oris (noma): An early sign of acute lymphoblastic leukemia relapse.
- Published in:
- 2018
- By:
- Publication type:
- case study
A review of pulse therapy in 74 patients with pemphigus.
- Published in:
- 2018
- By:
- Publication type:
- letter
Urocytological evaluation of pemphigus patients on long term cyclophosphamide therapy: A cross sectional study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Dexamethasone-cyclophosphamide pulse therapy in systemic sclerosis: A retrospective study from a tertiary care hospital.
- Published in:
- 2017
- By:
- Publication type:
- letter
Guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis: An Indian perspective.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Pemphigus in North-Western Yemen: A therapeutic study of 75 cases.
- Published in:
- 2016
- By:
- Publication type:
- letter
Treatment of prurigo nodularis with dexamethasone-cyclophosphamide pulse therapy.
- Published in:
- 2016
- By:
- Publication type:
- case study
Intermediate doses of rituximab used as adjuvant therapy in refractory pemphigus.
- Published in:
- Indian Journal of Dermatology, Venereology & Leprology, 2014, v. 80, n. 4, p. 300, doi. 10.4103/0378-6323.136832
- By:
- Publication type:
- Article
Factors affecting the duration of phase I of dexamethasone - cyclophosphamide pulse therapy.
- Published in:
- Indian Journal of Dermatology, Venereology & Leprology, 2014, v. 80, n. 4, p. 296, doi. 10.4103/0378-6323.136831
- By:
- Publication type:
- Article
Treatment of pemphigus: An Indian perspective.
- Published in:
- 2014
- By:
- Publication type:
- Editorial
Assessment of the therapeutic benefit of dexamethasone cyclophosphamide pulse versus only oral cyclophosphamide in phase II of the dexamethasone cyclophosphamide pulse therapy: A preliminary prospective randomized controlled study.
- Published in:
- Indian Journal of Dermatology, Venereology & Leprology, 2013, v. 79, n. 1, p. 70, doi. 10.4103/0378-6323.104672
- By:
- Publication type:
- Article
Randomized open comparative trial of dexamethasone-cyclophosphamide pulse and daily oral cyclophosphamide versus cyclophosphamide pulse and daily oral prednisolone in pemphigus vulgaris.
- Published in:
- Indian Journal of Dermatology, Venereology & Leprology, 2009, v. 75, n. 5, p. 476, doi. 10.4103/0378-6323.55390
- By:
- Publication type:
- Article
Prolonged remission of pemphigus induced by dexamethasone-cyclophosphamide pulse therapy.
- Published in:
- 2007
- By:
- Publication type:
- letter
Urticarial papules and plaques on the trunk.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Successful treatment of scleromyxedema with dexamethasone cyclophosphamide pulse therapy.
- Published in:
- 2005
- By:
- Publication type:
- case study
Effect of Cyclophosphamide on Expression of MMP-9 and TGF-β1 in Renal Tissue of Rats with Diabetes Mellitus.
- Published in:
- Cell Biochemistry & Biophysics, 2015, v. 72, n. 2, p. 399, doi. 10.1007/s12013-014-0474-7
- By:
- Publication type:
- Article
Effect of Rituximab on Serum Levels of Anti-C1q and Antineutrophil Cytoplasmic Autoantibodies in Refractory Severe Lupus Nephritis.
- Published in:
- Cell Biochemistry & Biophysics, 2015, v. 72, n. 1, p. 197, doi. 10.1007/s12013-014-0437-z
- By:
- Publication type:
- Article
Therapeutic Effect of Strontium Ranelate on Bone in Chemotherapy-Induced Osteopenic Rats via Increased Bone Volume and Reduced Bone Loss.
- Published in:
- Biological Trace Element Research, 2019, v. 187, n. 2, p. 472, doi. 10.1007/s12011-018-1401-3
- By:
- Publication type:
- Article
Protective Effects of Selenium on Cyclophosphamide-Induced Oxidative Stress and Kidney Injury.
- Published in:
- Biological Trace Element Research, 2018, v. 185, n. 1, p. 116, doi. 10.1007/s12011-017-1231-8
- By:
- Publication type:
- Article
Role of Vital Trace Elements in Nanocurcumin-Centered Formulation: A Novel Approach to Resuscitate the Immune System.
- Published in:
- Biological Trace Element Research, 2018, v. 182, n. 2, p. 265, doi. 10.1007/s12011-017-1082-3
- By:
- Publication type:
- Article
Long-term follow-up in lupus nephritis patients treated with rituximab - clinical and histopathological response.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
Low-dose tacrolimus in treating lupus nephritis refractory to cyclophosphamide: a prospective cohort study.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
Rituximab versus oral cyclophosphamide for treatment of relapses of proliferative lupus nephritis: a clinical observational study.
- Published in:
- Current Medical Literature: Rheumatology, 2013, v. 32, n. 1, p. 22
- By:
- Publication type:
- Article
Systemic Lupus Erythematosus.
- Published in:
- Current Medical Literature: Rheumatology, 2010, v. 29, n. 1, p. 25
- Publication type:
- Article
Fractionated oral dosing and its effect on cyclophosphamide pharmacokinetics in dogs with high‐grade multicentric lymphoma.
- Published in:
- Veterinary & Comparative Oncology, 2023, v. 21, n. 1, p. 20, doi. 10.1111/vco.12856
- By:
- Publication type:
- Article
Procarbazine, prednisolone and cyclophosphamide oral combination chemotherapy protocol for canine lymphoma.
- Published in:
- Veterinary & Comparative Oncology, 2022, v. 20, n. 3, p. 613, doi. 10.1111/vco.12814
- By:
- Publication type:
- Article
Clinical outcome of dogs diagnosed with canine inflammatory mammary cancer treated with metronomic cyclophosphamide, a cyclooxygenase‐2 inhibitor and toceranib phosphate.
- Published in:
- Veterinary & Comparative Oncology, 2022, v. 20, n. 1, p. 179, doi. 10.1111/vco.12760
- By:
- Publication type:
- Article
Adjuvant doxorubicin vs metronomic cyclophosphamide and meloxicam vs surgery alone for cats with mammary carcinomas: A retrospective study of 137 cases.
- Published in:
- Veterinary & Comparative Oncology, 2021, v. 19, n. 4, p. 714, doi. 10.1111/vco.12660
- By:
- Publication type:
- Article
Response rate to a single dose of vinblastine administered to dogs with treatment‐naive multicentric lymphoma.
- Published in:
- Veterinary & Comparative Oncology, 2018, v. 16, n. 4, p. 636, doi. 10.1111/vco.12433
- By:
- Publication type:
- Article
Glutathione‐S‐transferase‐theta genotypes and the risk of cyclophosphamide toxicity in dogs.
- Published in:
- Veterinary & Comparative Oncology, 2018, v. 16, n. 4, p. 529, doi. 10.1111/vco.12411
- By:
- Publication type:
- Article
Engineering controls in veterinary oncology: A survey of 148 ACVIM board‐certified oncologists and environmental surveillance in 20 specialty hospitals.
- Published in:
- Veterinary & Comparative Oncology, 2018, v. 16, n. 3, p. 385, doi. 10.1111/vco.12390
- By:
- Publication type:
- Article
Furosemide for prevention of cyclophosphamide-associated sterile haemorrhagic cystitis in dogs receiving metronomic low-dose oral cyclophosphamide.
- Published in:
- Veterinary & Comparative Oncology, 2017, v. 15, n. 4, p. 1468, doi. 10.1111/vco.12292
- By:
- Publication type:
- Article
Potency and stability of compounded formulations of chlorambucil, melphalan and cyclophosphamide.
- Published in:
- Veterinary & Comparative Oncology, 2017, v. 15, n. 4, p. 1558, doi. 10.1111/vco.12301
- By:
- Publication type:
- Article
Potency and stability of compounded cyclophosphamide: a pilot study.
- Published in:
- Veterinary & Comparative Oncology, 2017, v. 15, n. 3, p. 706, doi. 10.1111/vco.12210
- By:
- Publication type:
- Article
Phase I lead-in and subsequent randomized trial assessing safety and modulation of regulatory T cell numbers following a maximally tolerated dose doxorubicin and metronomic dose cyclophosphamide combination chemotherapy protocol in tumour-bearing dogs.
- Published in:
- Veterinary & Comparative Oncology, 2017, v. 15, n. 2, p. 421, doi. 10.1111/vco.12179
- By:
- Publication type:
- Article
Comparison of doxorubicin-cyclophosphamide with doxorubicin-dacarbazine for the adjuvant treatment of canine hemangiosarcoma.
- Published in:
- Veterinary & Comparative Oncology, 2017, v. 15, n. 1, p. 25, doi. 10.1111/vco.12139
- By:
- Publication type:
- Article